Kyle Acierno is Co-Founder and CEO of Exobiosphere, a pioneering space biotechnology company operating at the intersection of microgravity science and drug discovery, and a prominent leader known for driving innovation across space, robotics, and life sciences.

Kyle holds a Master of Space Studies from the International Space University and a Bachelor's in International Security from Simon Fraser University, and has traveled to over 110 countries, shaping a uniquely global perspective on the space industry.

Kyle sits on the board of World Space Week, the IAF Industry Relations Committee, and previously served as Chair of the Technical Committee of the Hague Space Resources Working Group, and in 2015 won the Space Generation Advisory Council's Space Leader award.

Prior to Exobiosphere, Kyle served as CEO of ispace US and Managing Director of ispace Europe, then as Managing Director of OffWorld Europe, where he opened four offices, hired over 100 people, and closed over $100M in sales.

Exobiosphere has grown from 3 to 15 employees, secured over 2 million euros in commercial deals and grants through Luxembourg's Fit 4 Start accelerator, raised a 2 million euro Seed round, and won a $1M investment from legendary investor Tim Draper.